Zydus Wellness
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Zydus Wellness is currently navigating a transitional phase marked by mixed performance across its product portfolio. Management has highlighted a softening in seasonal products like Glucon-D and Nycil due to adverse weather, yet they remain optimistic about robust growth in non-seasonal segments, particularly through recent acquisitions and innovation in brands like RiteBite. This strategic focus aligns with Vista's forecast of improving margins, supported by operational efficiencies and a diversified product mix. However, the company faces headwinds from ongoing weather sensitivity and integration challenges in international markets. The FMCG sector's overall expansion, driven by volume growth and strategic price adjustments, provides a favorable backdrop, although competitive pressures and rising costs remain concerns. Over the next 12-24 months, Zydus Wellness's key opportunities lie in leveraging e-commerce and quick commerce channels, while watchpoints include the impact of geopolitical disruptions and seasonal demand fluctuations. Vista's outlook reflects a cautious stance, with a strong sell recommendation, as the stock trades at a premium valuation despite expected upside challenges
Why We Like This Stock
- Strong growth in non-seasonal segments driven by acquisitions and innovation
- Management's focus on operational efficiency and margin expansion
- Positive alignment with global health and wellness trends enhancing market opportunities
Things To Watch Out For
- Soft performance in core seasonal products due to adverse weather conditions
- Integration challenges from recent acquisitions impacting profitability
- Rising costs and competitive pressures affecting margin stability
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 2,328 | 2,709 | 3,961 | 4,511 | 5,399 |
| Profit Before Tax (Cr.) | 272 | 344 | 271 | 188 | 301 |
| PBT Margin | 11.7% | 12.7% | 684.2% | 4.2% | 5.6% |
| Net Profit (Cr.) | 272 | 344 | 235 | 164 | 262 |
| Earnings Per Share | 8.6 | 10.8 | 7.4 | 5.1 | 8.2 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Mirae Asset | ▲ Buy | 552 | 14-May-2026 |
| Motilal Oswal | ▲ Buy | 665 | 06-Aug-2026 |
Company Overview
Show Company Profile
Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in India, the Middle East, Asia, Africa, the Oceania, and internationally. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon-D brand; and I'm lite a blended sugar coated with stevia. The company also offers a range of skincare products, such as soap-free face washes, face masks, scrubs, and leave-on-products under the Everyuth brand; prickly heat and cooling powder, and hand sanitizer under the Nycil brand; and probiotic butter spread, table spread, ghee, butter, cholesterol fat-free spread, mayonnaise, and chocolate spread under the Nutralite brand. It also exports its products. The company was formerly known as Carnation Nutra Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is headquartered in Ahmedabad, India. Zydus Wellness Limited is a subsidiary of Zydus Lifesciences Limited.